⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMRN News
BioMarin Pharmaceuticals Inc
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
prnewswire.com
BMRN
From Chip to Grid to Orbit: Yotta 2026 Launches Full Agenda
globenewswire.com
AMAT
KLAC
LRCX
NVDA
AMD
INTC
MSFT
GOOG
AMZN
DLR
XEL
GE
BE
BMRN
CDNS
CRUS
ETN
IREN
JCI
ON
TT
VRT
Form 8-K/A
sec.gov
BMRN
U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia
prnewswire.com
BMRN
בית הספר למנהל עסקים של לונדון מכריז על קבלת תרומה של 25 מיליון ליש"ט מקרן דיוויד ומולי פיוט ומדיוויד ומולי פיוט
globenewswire.com
ALNY
TARS
PHG
BMRN
London Business School announces £25 million gift from the David and Molly Pyott Foundation and David and Molly Pyott
globenewswire.com
ALNY
TARS
BMRN
Guide to Avoid Pitfalls in Primary Cell Procurement Released! Cloud-Clone Corp. Unveils Buying Guide for Novice Researchers to Boost Research Efficiency
accessnewswire.com
LLY
AZN
BMRN
AI Infrastructure’s Toughest Questions Take Center Stage at Yotta 2026
globenewswire.com
BMRN
CDNS
CRUS
CRI
DOO
ETN
HPE
IREN
JCI
TRC
VRT
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026
prnewswire.com
BMRN
National Organization for Rare Disorders Appoints Kathryn Lowell as Executive Vice President, Government Affairs
prnewswire.com
BMRN